Obama’s precision medicine initiative looks set for bipartisan support, Valeant has offered $296 million to buy Dendreon and researchers say Roche’s Tamiflu works.
Talking, braille labels to show up in mailboxes
January 5, 2015
5:13 pm
A CVS Health/American Council of the Blind collaboration means some visually impaired patients will soon have more engaging prescription labels.
A mélange of new treatments awaiting approval and a lack of patient support are driving down drug utilization for Gilead’s HCV blockbuster, according to a new study.
Biologics have higher psoriatic arthritis adherence
August 26, 2014
4:09 pm
A study of psoriatic arthritis patients found greater adherence among patients whose initial treatment was a biologic, compared to those who started with a non-biologic treatment.
Researchers at the Brigham and Women’s Hospital found that continuity in color and shape have a significant impact on whether patients stick with a prescription regimen.
